# Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

> clinical trial · VERIFIED · 2026-07-06

Status: ACTIVE_NOT_RECRUITING · Sponsor: Memorial Sloan Kettering Cancer Center · Condition: Brain Cancer

- Company: Memorial Sloan Kettering Cancer Center
- Sector: Brain Cancer
- Primary source: https://clinicaltrials.gov/study/NCT01892397

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.